Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Targeted Therapy
  •  Adjuvant Therapy
  •  Immunology
  •  Melanoma/Skin Cancer
  •  Gastrointestinal Cancer
  •  Lymphoma
  •  Lung Cancers
  •  Chemoprevention

Abstract

Citation: Clin Oncol. 2018;3(1):1499.DOI: 10.25107/2474-1663.1499

Long-Term Follow-Up of Two Cases of Primary Pulmonary Plasmacytoma

Ioannis Bougioukas, Mohamad Shadi Alzin, Elke Eltze, Ralf Seipelt and Hanno Huwer

Department of Cardiothoracic Surgery, Voelklingen Heart Centre, Germany
Institute for Pathology, Saarbruecken-Rastpfuhl, Germany

*Correspondance to: Ioannis Bougioukas 

 PDF  Full Text Case Presentation | Open Access

Abstract:

Primary pulmonary plasmacytoma is a very rare type of extramedullary plasmacytoma and can potentially progress to multiple myeloma. Certain variability in the therapeutic management of this condition exists because of its rarity. Its presentation as a single pulmonary mass renders both surgery and radiotherapy as attractive therapeutical options. We present the 10-year-follow-up report of two cases of primary pulmonary plasmacytoma, both managed with surgical sublobar resection solely. In the first case, the follow-up was completely uneventful. In the second case, a new pulmonary mass was demonstrated seven years after the resection; however biopsy of this mass excluded both malignancy and disease progression. The actual follow-up of this patient showed no further change of the radiological finding. The possibility of existence of an amyloidoma on the old surgical scar tissue has been considered. Looking at the scarce literature, we conclude that complete surgical resection accompanied by regular aftercare is a rational therapeutical concept for primary pulmonary plasmacytoma. Performance of sublobar resection instead of a more extensive lobectomy is sufficient minimizing operative risk and hospital stay.

Keywords:

Plasmacytoma; Amyloid; Lung

Cite the Article:

Bougioukas I, Alzin MS, Eltze E, Seipelt R, Huwer H. Long-Term Follow-Up of Two Cases of Primary Pulmonary Plasmacytoma. Clin Oncol. 2018; 3: 1499.

Search Our Journal

Journal Indexed In

Articles in PubMed

NMR Metabolomics in Ionizing Radiation
 PubMed  PMC  PDF  Full Text
LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Immunohistochemistry Biomarkers in Bladder Cancer: The Old and the New Immunohistochemistry Markers in Bladder Cancer
 Abstract  PDF  Full Text
NLRP3 Inflammasome Enhances Tumor Growth
 Abstract  PDF  Full Text
View More...